Shmuel Cabilly
Director/Board Member at REDHILL BIOPHARMA LTD.
Net worth: 216 373 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Dror Ben-Asher | M | 59 | 15 years | |
Amnon Peled | M | - |
Biokine Therapeutics Ltd.
Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | 24 years |
Natalie Yivgi-Ohana | M | - |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | 12 years |
kristin Comer | F | - | - | |
Gilead Raday | M | 49 | 14 years | |
Ephraim Aharonson | M | - |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | 12 years |
Roni Yekutielov | M | - |
Ofakim Hi-Tech Ventures Ltd.
Ofakim Hi-Tech Ventures Ltd. Investment ManagersFinance Ofakim Hi-Tech Ventures Ltd. (Ofakim Hi-Tech Ventures) is a venture capital subsidiary of Capital Point Ltd. founded in 1991. The firm is headquartered in Ofakim, Israel. | 12 years |
Uri Yogev | M | - |
BioCep Ltd.
BioCep Ltd. Miscellaneous Commercial ServicesCommercial Services BioCep Ltd. develops cell separation technologies. The firm also manufactures and sells cutting-edge technologies for cell isolation. Its product, SmartSep enables cell recovery with magnetic beads removal process before infusion to the patient. The company was founded by Ofer Klein and Aharon Lamish on July 4, 2006 and is headquartered in Ness Ziona, Israel. | 5 years |
David Wasserman | M | - | 7 years | |
Oz Vachtenberg | M | - |
DenTack Implants Ltd.
DenTack Implants Ltd. Medical SpecialtiesHealth Technology DenTack Implants Ltd. develops, manufactures and sells dental implants. Its products include implants, prosthetic components and surgical tools. The firm’s dental implants provide an implant solution for patients with short bone height as an alternative to surgical bone augmentation treatment. The company was founded by Oz Vachtenberg in 2006 and is headquartered in Kfar Saba, Israel. | 18 years |
Yehuda Kahane | M | 79 |
Pango Mobile Parking Ltd.
Pango Mobile Parking Ltd. Information Technology ServicesTechnology Services Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel.
Ofakim Hi-Tech Ventures Ltd.
Ofakim Hi-Tech Ventures Ltd. Investment ManagersFinance Ofakim Hi-Tech Ventures Ltd. (Ofakim Hi-Tech Ventures) is a venture capital subsidiary of Capital Point Ltd. founded in 1991. The firm is headquartered in Ofakim, Israel. | - |
Kenneth Reed | M | 70 | 15 years | |
Adi Frish | M | 54 | 14 years | |
Alla Felder | F | 50 | 5 years | |
Alon Bloomenfeld | M | - |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | 12 years |
Eric Emile Swenden | M | 80 | 14 years | |
Ofer Tsimchi | M | 64 | 13 years | |
Uriel Halavee | M | - |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | 12 years |
Ira N. Kalfus | M | 63 | - | |
Ofer Klein | M | - |
BioCep Ltd.
BioCep Ltd. Miscellaneous Commercial ServicesCommercial Services BioCep Ltd. develops cell separation technologies. The firm also manufactures and sells cutting-edge technologies for cell isolation. Its product, SmartSep enables cell recovery with magnetic beads removal process before infusion to the patient. The company was founded by Ofer Klein and Aharon Lamish on July 4, 2006 and is headquartered in Ness Ziona, Israel. | 18 years |
Rick Scruggs | M | 64 | 8 years | |
Yaki Skuler-Sella | M | - |
DenTack Implants Ltd.
DenTack Implants Ltd. Medical SpecialtiesHealth Technology DenTack Implants Ltd. develops, manufactures and sells dental implants. Its products include implants, prosthetic components and surgical tools. The firm’s dental implants provide an implant solution for patients with short bone height as an alternative to surgical bone augmentation treatment. The company was founded by Oz Vachtenberg in 2006 and is headquartered in Kfar Saba, Israel. | 16 years |
Guy Goldberg | M | 48 | 12 years | |
Zeev Milbauer | M | 69 |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | 12 years |
Patricia Anderson | F | - | 7 years | |
Mahalakshmi Radhakrishnan | M | - |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | 1 years |
Alexandra Okmian | F | - | - | |
Anthony Michael Stanton | M | 67 |
Biokine Therapeutics Ltd.
Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | - |
Rob Jackson | M | - | 5 years | |
Yair Shamir | M | 79 |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | 5 years |
Yitzhak Meyuhas | M | - |
Biokine Therapeutics Ltd.
Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | - |
Philippe Schaison | M | 62 |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | 5 years |
Limor Sela | M | - |
Pango Mobile Parking Ltd.
Pango Mobile Parking Ltd. Information Technology ServicesTechnology Services Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel. | - |
Michelle Snelling | F | - | 5 years | |
June Almenoff | M | 67 | 5 years | |
Amir Lass | M | - |
Irody, Inc.
| - |
Joyce Cramer | F | - |
Irody, Inc.
| - |
Joshua Moshonov | M | - |
DenTack Implants Ltd.
DenTack Implants Ltd. Medical SpecialtiesHealth Technology DenTack Implants Ltd. develops, manufactures and sells dental implants. Its products include implants, prosthetic components and surgical tools. The firm’s dental implants provide an implant solution for patients with short bone height as an alternative to surgical bone augmentation treatment. The company was founded by Oz Vachtenberg in 2006 and is headquartered in Kfar Saba, Israel. | - |
Mark L. Levitt | M | - | 7 years | |
Razi Ingber | M | - | 1 years | |
Zafrira Avnur | M | 73 |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | 5 years |
Michael Ron | M | - |
Pango Mobile Parking Ltd.
Pango Mobile Parking Ltd. Information Technology ServicesTechnology Services Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel. | - |
Doron Halevy | M | - |
Pango Mobile Parking Ltd.
Pango Mobile Parking Ltd. Information Technology ServicesTechnology Services Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel. | - |
Eyal Lifschitz | M | - |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | 5 years |
Ora Elharar-Soffer | F | - |
BioCep Ltd.
BioCep Ltd. Miscellaneous Commercial ServicesCommercial Services BioCep Ltd. develops cell separation technologies. The firm also manufactures and sells cutting-edge technologies for cell isolation. Its product, SmartSep enables cell recovery with magnetic beads removal process before infusion to the patient. The company was founded by Ofer Klein and Aharon Lamish on July 4, 2006 and is headquartered in Ness Ziona, Israel. | - |
Tomer Kariv | M | 62 |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | 8 years |
David Dolev | M | - |
Ofakim Hi-Tech Ventures Ltd.
Ofakim Hi-Tech Ventures Ltd. Investment ManagersFinance Ofakim Hi-Tech Ventures Ltd. (Ofakim Hi-Tech Ventures) is a venture capital subsidiary of Capital Point Ltd. founded in 1991. The firm is headquartered in Ofakim, Israel. | - |
Yoav Kahane | M | 48 |
Pango Mobile Parking Ltd.
Pango Mobile Parking Ltd. Information Technology ServicesTechnology Services Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel. | - |
Israel Schreiber | M | - |
Ornim Medical Ltd.
Ornim Medical Ltd. Medical SpecialtiesHealth Technology Ornim Medical Ltd. provides medical devices and monitering tools. The company is headquartered in Kfar Saba, Israel. | 12 years |
John Cox | M | 61 |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012. | 5 years |
Ori Shilo | M | 58 | - | |
Nissim Darvish | M | 59 |
Ornim Medical Ltd.
Ornim Medical Ltd. Medical SpecialtiesHealth Technology Ornim Medical Ltd. provides medical devices and monitering tools. The company is headquartered in Kfar Saba, Israel. | - |
Yehoshua Gleitman | M | 74 |
Ofakim Hi-Tech Ventures Ltd.
Ofakim Hi-Tech Ventures Ltd. Investment ManagersFinance Ofakim Hi-Tech Ventures Ltd. (Ofakim Hi-Tech Ventures) is a venture capital subsidiary of Capital Point Ltd. founded in 1991. The firm is headquartered in Ofakim, Israel. | - |
Adi Goldin | M | 49 |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | 11 years |
Eitan Friedman | M | - |
DenTack Implants Ltd.
DenTack Implants Ltd. Medical SpecialtiesHealth Technology DenTack Implants Ltd. develops, manufactures and sells dental implants. Its products include implants, prosthetic components and surgical tools. The firm’s dental implants provide an implant solution for patients with short bone height as an alternative to surgical bone augmentation treatment. The company was founded by Oz Vachtenberg in 2006 and is headquartered in Kfar Saba, Israel. | - |
Yoram Romem | M | - |
Pango Mobile Parking Ltd.
Pango Mobile Parking Ltd. Information Technology ServicesTechnology Services Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel. | - |
Noah Lewis | M | - |
Ornim Medical Ltd.
Ornim Medical Ltd. Medical SpecialtiesHealth Technology Ornim Medical Ltd. provides medical devices and monitering tools. The company is headquartered in Kfar Saba, Israel. | - |
Adir Inbar | M | - |
Pango Mobile Parking Ltd.
Pango Mobile Parking Ltd. Information Technology ServicesTechnology Services Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel. | 10 years |
Assaf Segal | M | 51 |
Biokine Therapeutics Ltd.
Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | 5 years |
Reza Fathi | M | 69 | 14 years | |
Shani Maurice | F | - | - | |
Terry F. Plasse | M | - | - | |
H. Laurence Shaw | M | - |
Biokine Therapeutics Ltd.
Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Dan Suesskind | M | 80 | - | |
Nurit Benjamini | F | 57 | - | |
Danielle Abramson | M | - | - | |
Ben Martie | M | - | - | |
Alicia Rotbard | F | 78 | 4 years | |
Micha Ben-Chorin | M | 55 | 7 years | |
Giuseppe Cipriano | M | 67 | - | |
Uri Hananel Aharon | M | 43 | - | |
Aida Bibliowicz | F | - | - | |
Valerie Graceffa | F | - | - | |
Einav Nagar-Brenner | F | 42 | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
Israel | 72 | 97.30% |
United States | 2 | 2.70% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Shmuel Cabilly
- Personal Network